Mar 13, 2008 7:30am EDT Rigel Announces Participation in Upcoming Investor and Partnering Conferences
Jan 09, 2008 7:30am EST Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders